Table 1.
Sample | SHX | Dead (%) | Injured (%) | Septated (%) | Mean Length (µM) |
---|---|---|---|---|---|
wild type | − | 0.13 | 0.74 | 31 | 3.8 |
wild type | + | 0.29 | 2.1 | 4 | 3.0 |
obgE::Tn5 | − | 2.8 | 2.9 | 32 | 4.6 |
obgE::Tn5 | + | 13 | 8.2 | 2 | 3.4 |
relA251 | − | 0.6 | 2.7 | n.d. | n.d. |
relA251 | + | 3.6 | 4.8 | n.d. | n.d. |
obgE::Tn5 relA | − | 1.8 | 6.2 | n.d. | n.d. |
obgE::Tn5 relA | + | 18 | 10 | n.d. | n.d. |
SHX, (+) serine hydroxamate treatment for 90 min; (−) no treatment.